These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 906678

  • 1. [Animal-experiment studies on the effect of magnesium and vitamin B 6 on calcium-oxalate nephrolithiasis].
    Schneider HJ, Hesse A, Berg W, Kirsten J, Nickel H.
    Z Urol Nephrol; 1977 Jun; 70(6):419-27. PubMed ID: 906678
    [Abstract] [Full Text] [Related]

  • 2. [Experimental evidence of magnesium salts for treatment of calcium oxalate nephrolithiasis in an animal model based on sodium oxalate and a cyclooxygenase 2 selective inhibitor].
    Spasov AA, Iezhitsa IN, Kharitonova MV, Kravchenko MS, Snigur GL, Pisarev VB.
    Patol Fiziol Eksp Ter; 2013 Jun; (2):50-5. PubMed ID: 24000715
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of anticalculus management in the rat.
    Selikowitz SM, Olsson CA.
    Invest Urol; 1976 Sep; 14(2):120-3. PubMed ID: 972003
    [Abstract] [Full Text] [Related]

  • 4. Calcium oxalate lithiasis produced by pyridoxine deficiency and inhibition with high magnesium diets.
    Lyon ES, Borden TA, Ellis JE, Vermeulen CW.
    Invest Urol; 1966 Sep; 4(2):133-42. PubMed ID: 5926625
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J, Nonomura M, Okada Y, Yoshida O, Takashima M, Itokawa Y.
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [Abstract] [Full Text] [Related]

  • 6. [Metabolism of vitamin B6, citric and oxalic acids, calcium and magnesium in nephrolithiasis].
    Izashvili NP, Kasabian EV.
    Urol Nefrol (Mosk); 1973 May; 38(3):9-13. PubMed ID: 4756582
    [No Abstract] [Full Text] [Related]

  • 7. Formation of calcium oxalate urolithiasis in experiment and its inhibition by pyridoxine and magnesium.
    Krídl J, Zvara V, Revúsová V, Ondrus B.
    Czech Med; 1986 May; 9(3):124-9. PubMed ID: 3095070
    [Abstract] [Full Text] [Related]

  • 8. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones.
    Gershoff SN, Prien EL.
    Am J Clin Nutr; 1967 May; 20(5):393-9. PubMed ID: 6023850
    [No Abstract] [Full Text] [Related]

  • 9. The effect of magnesium and pyridoxine on formation of calcium oxalate sones in man.
    Nutr Rev; 1967 Oct; 25(10):304-5. PubMed ID: 4861850
    [No Abstract] [Full Text] [Related]

  • 10. Calcium oxalate renal stones.
    Prien EL.
    Annu Rev Med; 1975 Oct; 26():173-9. PubMed ID: 1096755
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of feeding on the composition of foreign-body stones in animal experiments. II. Calcium oxalate and magnesium therapy].
    Schneider HJ, Hesse A, Hensel K, Unger G, Berg W.
    Z Urol Nephrol; 1975 Jan; 68(1):1-5. PubMed ID: 1229743
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical studies of Magurlit granulates].
    Frang D, Verebélyi A, Nagy Z.
    Acta Chir Acad Sci Hung; 1978 Jan; 19(4):363-72. PubMed ID: 757918
    [Abstract] [Full Text] [Related]

  • 13. Nephrolithiasis: recent advances in therapy.
    Erwin DT.
    South Med J; 1976 Jul; 69(7):935-7. PubMed ID: 941065
    [Abstract] [Full Text] [Related]

  • 14. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P, Schmidt P, Zazgornik J, Kopsa H, Minar E.
    Proc Eur Dial Transplant Assoc; 1983 Jul; 20():417-21. PubMed ID: 6657665
    [Abstract] [Full Text] [Related]

  • 15. The effects of magnesium and pH on experimental calcium oxalate stone disease.
    Borden TA, Lyon ES.
    Invest Urol; 1969 Jan; 6(4):412-22. PubMed ID: 5773525
    [No Abstract] [Full Text] [Related]

  • 16. [Inhibition of calcium oxalate urolithiasis with pyridoxine and magnesium in an experiment].
    Krídl J, Zvara V, Revúsová V, Gratzlová J, Ondrus B.
    Bratisl Lek Listy; 1984 Jan; 81(1):21-8. PubMed ID: 6692164
    [No Abstract] [Full Text] [Related]

  • 17. [The significance of oxaluria reduction in pyridoxine prevention of Ca-oxalate nephrolithiasis (author's transl)].
    Revúsová V, Gratzlová J, Zvara V, Krídl J, Suchánek B.
    Cas Lek Cesk; 1982 Feb 12; 121(6):163-6. PubMed ID: 7060073
    [No Abstract] [Full Text] [Related]

  • 18. [Possibilities of pharmacological prevention of oxalate calculi].
    Terhorst B, Lutzeyer W.
    Z Urol Nephrol; 1972 Nov 12; 65(11):815-25. PubMed ID: 4665913
    [No Abstract] [Full Text] [Related]

  • 19. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
    Yendt ER, Cohanim M.
    Clin Invest Med; 1986 Nov 12; 9(1):44-50. PubMed ID: 3955921
    [Abstract] [Full Text] [Related]

  • 20. [Effects of mangesium salts and their combinations with vitamin B6 on oxalates crystalluria in rats fed with pyridoxine-deficient diet].
    Spasov AA, Iezhitsa IN, Kharitonova MV, Kravchenko MS.
    Urologiia; 2009 Nov 12; (3):22-5. PubMed ID: 19670811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.